Bio-Rad Laboratories Inc (STU:BUWA)
€ 344.3 4.8 (1.41%) Market Cap: 9.37 Bil Enterprise Value: 9.16 Bil PE Ratio: 0 PB Ratio: 1.39 GF Score: 75/100

Q1 2022 Bio Rad Laboratories Inc Earnings Call Transcript

Apr 28, 2022 / 10:00PM GMT
Release Date Price: €477 (+0.59%)
Operator

Good afternoon. Thank you for attending today's Bio-Rad Laboratories Q1 2022 Financial Results Call. My name is Hannah, and I will be your moderator for today's call. (Operator Instructions)

I would now like to pass the conference over to our host, Ed Chung, Head of Investor Relations with Bio-Rad Laboratories. Please go ahead.

Yong Chung
Bio-Rad Laboratories, Inc. - VP of IR

Thanks, Hannah. Good afternoon, and thank you all for joining us. Today, we will review the first quarter 2022 financial results and provide an update on key business trends for Bio-Rad. With me on the phone today are Norman Schwartz, our Chief Executive Officer; Ilan Daskal, Executive Vice President and Chief Financial Officer; Andy Last, Executive Vice President and Chief Operating Officer; Simon May, President of the Life Science Group; and Dara Wright, President of the Clinical Diagnostics Group.

Before we begin our review, I would like to caution everyone that we will be making forward-looking statements about management's goals, plans and expectations, our future

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot